Zimmer Biomet
904 hedge funds and large institutions have $17.1B invested in Zimmer Biomet in 2026 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 314 increasing their positions, 305 reducing their positions, and 91 closing their positions.
4.3% more ownership
Funds ownership: 98.32% → 102.62% (+4.3%)
3% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 91
3% more repeat investments, than reductions
Existing positions increased: 314 | Existing positions reduced: 305
1% less call options, than puts
Call options by funds: $32.2M | Put options by funds: $32.5M
2% less capital invested
Capital invested by funds: $17.4B → $17.1B (-$315M)
1% less funds holding
Funds holding: 916 → 904 (-12)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$269M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$184M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$121M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$106M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$447M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$281M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$107M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$63.7M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$46M |
ZBH Hedge Fund Activity: Q2 2026 in Review
904 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2026, worth a combined $17.1B — down 1.8% from $17.4B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new ZBH positions and 91 closed out — a net gain of 3 holders — while 314 added to existing stakes and 305 trimmed.
The largest buyer was Capital International Investors, adding an estimated $269M. The largest seller was Franklin Resources, cutting an estimated $447M.
- 904 institutional investors held Zimmer Biomet (ZBH) as of Q2 2026, down from 916 in Q1 2026.
- Funds reported $17.1B of Zimmer Biomet stock for Q2 2026, down 1.8% quarter-over-quarter.
- 94 funds opened new Zimmer Biomet positions in Q2 2026 and 91 closed out, a net change of +3 holders.
- The largest Zimmer Biomet buyer in Q2 2026 was Capital International Investors, an estimated $269M added.
- The largest Zimmer Biomet seller in Q2 2026 was Franklin Resources, an estimated $447M sold.
Based on aggregated 13F filings for Q2 2026.